Murata F, Maeda M, Fukuda H.
Association between metabolic syndrome and participation in colorectal cancer screening in Japan: A retrospective cohort analysis using LIFE Study data.
Cancer Epidemiology 2023; 83: 102335.
Fukuda H, Murata F, Azuma S, Fujimoto M, Kudo S, Kobayashi Y, Saho K, Nakahara K, Ono R.
Development of a Data Platform for Monitoring Personal Health Records in Japan: The Sustaining Health by Integrating Next-generation Ecosystems (SHINE) Study.
Plos One 2023; 18(2): e0281512.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods in Japan: The VENUS Study.
Open Forum Infectious Diseases 2022; 9(12): ofac636.
Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, Kusaba H, Maruyama T, Baba E, AkashiK, Fukuda H.
Both new-onset and pre-existing hypertension are favorable indicators of clinical outcomes in patients treated with vascular endothelial growth factor inhibitors.
Circulation Journal 2024; 88(2):217-225.
Moriyama S, Hieda M, Kisanuki M, Kawano S, Yokoyama T, Fukata M, Kusaba H, Maruyama T, Baba E, Akashi K, Fukuda H.
Effect of renin-angiotensin system inhibitors in cancer patients treated with anti-VEGF therapy.
Open Heart 2022; 9(2): e002135.
Nishimura N, Fukuda H.
Risk of cardiovascular events leading to hospitalization after Streptococcus pneumoniae infection: A retrospective cohort LIFE study.
BMJ Open 2022; 12(11): e059713.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
International Journal of Infectious Disease 2022; 125: 58-60
Ishiguro C, Mimura W, Murata F, Fukuda H.
Development and Application of a Japanese Vaccine Database for Comparative Assessments in the Post-Authorization Phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study.
Vaccine 2022; 40(42): 6179-6186.
Adomi M, Maeda M, Murata F, Fukuda H.
Comparative risk of fracture in community-dwelling older adults initiating suvorexant versus Z-drugs: Results from LIFE Study.
Journal of the American Geriatrics Society 2023; 71(1): 109-120.
Fukuda H, Maeda M, Murata F, Murata Y.
Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study.
Journal of Alzheimer's Disease 2022; 90: 1177-1186.